Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,638 people get NUS articles and Market Currents by email alert.

Get email alerts on NUS »

NUS

Nu Skin Enterprises Inc.

5/25/2013, 7:33 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 9, 11:01 AM Nu Skin Enterprises (NUS) declares $0.30/share quarterly dividend, in line with previous. Forward yield 2.17%. For shareholders of record May 24. Payable June 12. Ex-div date May 22. (PR) Comment! [Dividends]
Thursday, May 2, 7:34 AM Nu Skin (NUS): Q1 EPS of $0.9 beats by $0.11. Revenue of $550.1M (+19% Y/Y) beats by $43.58M. (PR) Comment! [Earnings, Breaking News, Consumer]
Thursday, May 2, 12:05 AM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Wednesday, May 1, 5:30 PM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Thursday, April 18, 10:05 AM Nu Skin (NUS -0.6%) expects sales in China to topple the $1B mark this year and grow to $5B by 2018. The company will invest 350M yuan ($56.6M) in a new Shanghai office to help handle the rush of business. Comment! [Consumer, On the Move]
Tuesday, April 9, 11:57 AM Herbalife (HLF -0.7%) peer NuSkin (NUS -0.3%) breathes a sigh of relief, paring most of its losses on HLF's somewhat uneventful reopen and a lack of carnage following a NYSE record-long halt. Comment! [Healthcare, On the Move]
Tuesday, April 9, 10:33 AM Shares of Herbalife (HLF) peers are trading mixed after a bout of brief volatility on the KPMG news, as the event appears to be contained: Nu Skin (NUS -1.9%), USANA Health Sciences (USNA -0.7%), Blyth (BTH +0.4%). Comment! [Healthcare, On the Move, Consumer]
Tuesday, April 9, 10:23 AM Shares of Nu Skin (NUS -1.8%) trade lower after news of the resignation of Herbalife's auditor breaks. Comment! [Consumer, On the Move]
Tuesday, March 5, 1:56 PM Deutsche Bank says recent attacks on Nu Skin (NUS -2.8%) are "unfounded and misguided," and reiterates its Buy rating with a price target of $60. Deutsche calls the company one of the few growth names in its coverage that successfully overcomes difficult comparisons with better than expected results, and is likely to deliver high single to low double-digit growth again in 2013. 1 Comment [On the Move, Healthcare]
Thursday, February 14, 6:09 PM Nu-Skin (NUS) is active in the post hours session, drafting higher in the wake of Herbalife's (HLF) soaring run. Shares +4.5% AH. 2 Comments [On the Move]
Tuesday, February 12, 5:24 PM Nu Skin Enterprises (NUS) declares $0.30/share quarterly dividend, 50% increase from prior dividend of $0.20. Forward yield 2.87%. For shareholders of record Feb. 22. Payable Mar. 13. Ex-div date Feb. 20. (PR) Comment! [Dividends]
Thursday, February 7, 3:13 PM Nu Skin (NUS +2.2%) gets an added boost today from positive comments out of Canaccord's Scott Van Winkle. The analyst says that despite getting lumped in with the Herbalife (HLF) debate, Q1 guidance looks conservative as NUS remains in the "in the midst of a powerful product cycle." The firm reiterates its Buy rating but trims down its price target from $65 to $55. 1 Comment [On the Move, Healthcare]
Thursday, February 7, 1:59 PM Nu Skin (NUS +3.2%) trades higher in today's session, all but reversing yesterdays drubbing on the back of it's Q4 earnings report. The company delivered a decent quarter overall, showing strength in a number of Asian markets for its latest ageLOC products. Comment! [Healthcare, On the Move]
Wednesday, February 6, 9:06 AM More on Nu Skin (NUS -4.6%) Q4: net profit +20% to $59.2M, with growth driven by key markets such as Japan, South Korea and Mainland China, "where we continue to see tremendous results from our latest ageLOC products." Guidance: Q1 EPS of $0.75-0.77, below consensus of $0.84, and revenue of $500-510M vs $514.2M; FY EPS of $3.77-3.92 vs $3.97, and ups revenue outlook by $50M to $2.3-2.35B vs consensus of $2.33B. (PR) Comment! [Earnings, On the Move, Healthcare]
Wednesday, February 6, 7:36 AM Nu Skin (NUS): Q4 EPS of $0.97 beats by $0.03. Revenue of $588.2M (+19% Y/Y) beats by $8.7M. (PR) Comment! [Earnings, Breaking News, Consumer]
Wednesday, February 6, 12:05 AM Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED Comment! [Earnings]